Baclofen and Flecainide acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Baclofen (baclofen) and Flecainide acetate (flecainide acetate). Common drug interactions include dehydration among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Baclofen and Flecainide acetate. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Baclofen?

Baclofen has active ingredients of baclofen. It is often used in muscle spasms. eHealthMe is studying from 108,662 Baclofen users. Check the latest studies of Baclofen.

What is Flecainide acetate?

Flecainide acetate has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 7,176 Flecainide acetate users. Check the latest studies of Flecainide acetate.



On Jul, 30, 2026

59 people who take Baclofen and Flecainide acetate together, and have interactions are studied.

Baclofen and Flecainide acetate drug interactions.

What are the common drug interactions of Baclofen and Flecainide Acetate, by gender? *:

female:

  1. Dehydration (dryness resulting from the removal of water)
  2. Depression
  3. Diarrhoea
  4. Diplopia (double vision)
  5. Dizziness
  6. Dry eye (lack of adequate tears)
  7. Dry skin
  8. Dyspepsia (indigestion)
  9. Dyspnoea (difficult or laboured respiration)
  10. Erythema (redness of the skin)

male:

  1. Pain
  2. Abasia (inability to walk)
  3. Faecal incontinence (a lack of control over passing stool)
  4. Fall
  5. Gait disturbance
  6. Memory impairment
  7. Nausea (feeling of having an urge to vomit)
  8. Vascular dementia (vascular dementia is a general term describing problems with reasoning, planning, judgment, memory and other thought)
  9. Hypersomnia (excessive daytime sleepiness (eds))
  10. Acute respiratory failure

What are the common drug interactions of Baclofen and Flecainide Acetate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cardiac aneurysm (a condition that can occur after a myocardial infarction due to the inadequate resistance of the new scar tissue to the systolic pressure)

40-49:

  1. Pain
  2. Acute respiratory failure
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Ankle fracture
  5. Anxiety
  6. Aphasia (damage to the parts of the brain that control language)
  7. Blood creatinine increased
  8. Bone density decreased
  9. C-reactive protein increased
  10. Delirium (wild excitement)

50-59:

  1. Gait disturbance
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  4. Speech disorder
  5. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  6. Vomiting
  7. Fatigue (feeling of tiredness)
  8. Hot flush (sudden feelings of heat)
  9. Sleep disorder
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

60+:

  1. Fall
  2. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  3. Skin ulcer
  4. Asthenia (weakness)
  5. Depression
  6. Diarrhoea
  7. Dizziness
  8. Memory impairment
  9. Synovial cyst (cyst of joint filled with synovial fluid)
  10. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 20 people, 33.90%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 13.56%
  3. Constipation: 7 people, 11.86%
  4. Depression: 6 people, 10.17%
  5. Restless Leg Syndrome (a powerful urge to move your legs): 5 people, 8.47%
  6. Arrhythmias (irregular heartbeat): 4 people, 6.78%
  7. Pain: 4 people, 6.78%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 6.78%
  9. High Blood Pressure: 4 people, 6.78%
  10. Headache (pain in head): 3 people, 5.08%

* Approximation only. Some reports may have incomplete information.

Do you take Baclofen and Flecainide acetate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Baclofen and Flecainide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Baclofen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flecainide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Baclofen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flecainide acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on baclofen and flecainide acetate (the active ingredients of Baclofen and Flecainide acetate, respectively), and Baclofen and Flecainide acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: